SARS-CoV-2 antibodies and utility of point of care testing in Health Care Workers from a spanish University Hospital in Madrid
Mario Rodríguez-Domínguez(Instituto Cajal), Rafael Cantón(Instituto Ramón y Cajal de Investigación Sanitaria), Daniel Marcos-Mencía(Hospital Universitario Ramón y Cajal), Montserrat Ferré-Masferrer(Hospital Universitario Ramón y Cajal), Juan Carlos Galán(Instituto Ramón y Cajal de Investigación Sanitaria), Beatriz Romero‐Hernández(Instituto de Salud Carlos III), Marina Fernández-Escribano(Hospital Universitario Ramón y Cajal)
Cited by 3
Related Papers
The CTX-M β-lactamase pandemic
|Current Opinion in Microbiology|2006|1.1k
CTX-M Enzymes: Origin and Diffusion
|Frontiers in Microbiology|2012|955
CTX-M: changing the face of ESBLs in Europe
|Journal of Antimicrobial Chemotherapy|2006|923
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
|Eurosurveillance|2008|800
Dissemination of Clonally Related<i>Escherichia coli</i>Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
|Emerging infectious diseases|2008|699